Search Results - "BAAS, INGE O."

Refine Results
  1. 1

    Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports by van Dooijeweert, Carmen, van Diest, Paul J, Baas, Inge O, van der Wall, Elsken, Deckers, Ivette A G

    Published in Diagnostic pathology (11-05-2020)
    “…Histologic grade of ductal carcinoma in situ of the breast (DCIS) may become the single biomarker that decides whether patients will be treated. Yet, evidence…”
    Get full text
    Journal Article
  2. 2

    Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm by Baas, Inge O, Westermann, Anneke M, You, Benoit, Bolze, Pierre-Adrien, Seckl, Michael, Ghorani, Ehsan

    “…Immune checkpoint immunotherapy (CPI) targeting programmed cell death 1 (PD-1)/ligand (PD-L1) has been shown to be an effective treatment for gestational…”
    Get more information
    Journal Article
  3. 3

    Variation in breast cancer grading: the effect of creating awareness through laboratory-specific and pathologist-specific feedback reports in 16 734 patients with breast cancer by van Dooijeweert, Carmen, van Diest, Paul J, Baas, Inge O, van der Wall, Elsken, Deckers, Ivette A

    Published in Journal of clinical pathology (01-12-2020)
    “…Histological grade is widely used to guide the management of invasive breast cancer (IBC). Yet, substantial interlaboratory and intralaboratory grading…”
    Get more information
    Journal Article
  4. 4
  5. 5

    The impact of hyperbaric oxygen therapy on late radiation toxicity and quality of life in breast cancer patients by Batenburg, Marilot C. T., Maarse, Wies, van der Leij, Femke, Baas, Inge O., Boonstra, Onno, Lansdorp, Nina, Doeksen, Annemiek, van den Bongard, Desiree H. J. G., Verkooijen, Helena M.

    Published in Breast cancer research and treatment (01-09-2021)
    “…Purpose To evaluate symptoms of late radiation toxicity, side effects, and quality of life in breast cancer patients treated with hyperbaric oxygen therapy…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands by van Dooijeweert, Carmen, Deckers, Ivette A. G., Baas, Inge O., van der Wall, Elsken, van Diest, Paul J.

    Published in Breast cancer research and treatment (01-06-2019)
    “…Purpose Patient management of invasive breast cancer (IBC) is to a large extent based on hormone- and HER2-receptor assessment. High-quality, reliable receptor…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    p53 alterations in atypical alveolar hyperplasia of the human lung by Slebos, Robbert J.C, Baas, Inge O, Clement, Marjon J, Offerhaus, G.Johan A, Askin, Fredric B, Hruban, Ralph H, Westra, William H

    Published in Human pathology (01-08-1998)
    “…Atypical alveolar hyperplasia (AAH) is a potential precursor lesion from which lung adenocarcinomas arise and may be a good target for studying the early…”
    Get full text
    Journal Article
  14. 14

    Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells by Rozenveld-Geugien, Marjan, Baas, Inge O, van Gosliga, Djoke, Vellenga, Edo, Schuringa, Jan Jacob

    Published in Experimental hematology (01-05-2007)
    “…Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from…”
    Get full text
    Journal Article
  15. 15

    An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms by Baas, I O, Mulder, J W, Offerhaus, G J, Vogelstein, B, Hamilton, S R

    Published in The Journal of pathology (01-01-1994)
    “…Immunohistochemical detection of intranuclear p53 gene product may indicate mutation of the p53 suppressor gene on chromosome 17p. We used six commercially…”
    Get more information
    Journal Article
  16. 16

    K-ras oncogene activation in atypical alveolar hyperplasias of the human lung by WESTRA, W. H, BAAS, I. O, HRUBAN, R. H, ASKIN, F. B, WILSON, K, OFFERHAUS, G. J. A, SLEBOS, R. J. C

    Published in Cancer research (Chicago, Ill.) (01-05-1996)
    “…Atypical alveolar hyperplasia (AAH) is a potential precursor lesion from which lung adenocarcinomas arise and may be a good target for studying the early…”
    Get full text
    Journal Article
  17. 17

    Abstract P5-02-12: The effect of laboratory-specific feedback reports on grading variation of invasive breast cancer; results of a nationwide study in the Netherlands by van Dooijeweert, Carmen, van Diest, Paul J, Baas, Inge O, van der Wall, Elsken, Deckers, Ivette AG

    Published in Cancer research (Chicago, Ill.) (15-02-2020)
    “…Background: To date, histologic grade is widely used to guide therapeutic management of invasive breast cancer (IBC), as it remains one of the most well…”
    Get full text
    Journal Article
  18. 18

    The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals by Bargon, Claudia A, Mink van der Molen, Dieuwke R, Ernst, Miranda F, Batenburg, Marilot C. T, van Dam, Iris E, van Stam, Lilianne E, Baas, Inge O

    Published in Breast cancer research and treatment (01-02-2022)
    “…Purpose To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the…”
    Get full text
    Journal Article
  19. 19
  20. 20